Johnson & Johnson | Business Post

How I manage: ‘As a leader, the best thing you can give people is your time – quality time where you actively listen’

Promoting women in Stem (science, technology, engineering and maths) is now a priority and a passion for Anna Rafferty of Johnson & Johnson Ireland

This working life: ‘To achieve anything, you must choose a challenge and step out of your comfort zone’

Giving people the opportunity to master a task or challenge and empowering them to make decisions emphasises independence, adaptability and trust

Analysis: Can we end the pandemic?

The possibility for more infectious and deadly variants appears endless – it will take a number of measures and innovations to subdue Covid-19 in future

Analysis: Vaccine rollout keeps up to speed despite changes

With first doses for the over-65s and at-risk groups almost completed, new guidelines on vaccines should not greatly disrupt the programme

Johnson & Johnson will delay vaccine deliveries to EU as blood clots investigated

Ireland is in line for 2.2 million J&J shots this year but rollout is paused as US authorities look into six cases of brain blood clotting

J&J on track to get 2.2m one-jab vaccines to Ireland

Senior executive Johan Van Hoof says disparate global production centres will ensure the rollout won’t be affected by any US export ban

Johnson & Johnson vaccine gets green light from EMA

The single-dose Covid-19 vaccine has been approved for use in the EU, with first shipments to Ireland expected in mid-April

Vaccination of community pharmacists to start this week

Move could result in vaccines being administered to the public at local pharmacies by the end of March

Johnson & Johnson vaccine could be approved by mid-March

Ireland would be entitled to 2.2 million doses of the single-shot vaccine